Iovance Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.

About IOVA

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). 

CEO
Frederick G. Vogt
CEOFrederick G. Vogt
Employees
975
Employees975
Headquarters
San Carlos, California
HeadquartersSan Carlos, California
Founded
2007
Founded2007
Employees
975
Employees975

IOVA Key Statistics

Market cap
3.46B
Market cap3.46B
Price-Earnings ratio
-14.40
Price-Earnings ratio-14.40
Dividend yield
—
Dividend yield—
Average volume
11.49M
Average volume11.49M
High today
$7.66
High today$7.66
Low today
$7.29
Low today$7.29
Open price
$7.46
Open price$7.46
Volume
7.01M
Volume7.01M
52 Week high
$15.37
52 Week high$15.37
52 Week low
$2.08
52 Week low$2.08

Stock Snapshot

With a market cap of 3.46B, Iovance Biotherapeutics(IOVA) trades at $7.46. The stock has a price-to-earnings ratio of -14.40.

On 2026-11-18, Iovance Biotherapeutics(IOVA) stock moved within a range of $7.29 to $7.66. With shares now at $7.46, the stock is trading +2.3% above its intraday low and -2.6% below the session's peak.

Trading volume for Iovance Biotherapeutics(IOVA) stock has reached 7.01M, versus its average volume of 11.49M.

The stock's 52-week range extends from a low of $2.08 to a high of $15.37.

The stock's 52-week range extends from a low of $2.08 to a high of $15.37.

IOVA News

Simply Wall St 11h
What Iovance Biotherapeutics Stock AMTAGVI Lung Cancer Push Means For Shareholders

Iovance Biotherapeutics reported third quarter 2026 revenue of US$121.47 million and a net loss of US$22.27 million, reaffirmed full year 2026 revenue guidance...

What Iovance Biotherapeutics Stock AMTAGVI Lung Cancer Push Means For Shareholders

Analyst ratings

80%

of 10 ratings
Buy
80%
Hold
20%
Sell
0%

People also own

Based on the portfolios of people who own IOVA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.